Prevention of Jellyfish Stings
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00114894 |
Recruitment Status :
Completed
First Posted : June 20, 2005
Last Update Posted : April 25, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Bites and Stings | Other: Safe Sea ™ Other: Placebo | Phase 3 |
Jellyfish stings are a common occurrence among ocean-goers worldwide with an estimated 150 million envenomations annually. Fatalities and hospitalizations occur annually, particularly in the Indo-Pacific regions. A new topical jellyfish sting inhibitor based on the mucous coating of the clown fish prevents 85% of jellyfish stings in laboratory settings.
Clown fish inhabit within the tentacles of sea anemones, which have stinging cells similar to those of jellyfish, yet clown fish are not stung by the sea anemones. In controlled laboratory environments, the jellyfish sting inhibitor, Safe Sea™ when applied to volunteers' arms, prevented 100% of Chrysaora fuscescens stings and 70% of Chiropsalmus quadrumanus stings. Of the C. quadrumanus stings that occurred, their intensity was diminished. The field effectiveness is unknown. This is a field test to determine the real world effectiveness of Safe Sea to prevent jellyfish stings.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 12 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Field Study of the Prevention of Jellyfish Stings With a Topical Sting Inhibitor |
Study Start Date : | April 2004 |
Actual Primary Completion Date : | January 2006 |
Actual Study Completion Date : | February 2006 |
Arm | Intervention/treatment |
---|---|
Experimental: Safe Sea |
Other: Safe Sea ™
Safe Sea ™ applied one time at 2 mg/cm2 coverage |
Sham Comparator: Placebo
Coppertone® SPF15 (Schering-Plough)
|
Other: Placebo
Placebo Coppertone® SPF15 sunscreen(Schering-Plough) applied at 2 mg/cm2 body coverage |
- Incidence of jellyfish stings [ Time Frame: during recreational saltwater exposure (~30 min) ]
- Occurrence of seabather's eruption [ Time Frame: within 48 hours of saltwater exposure ]
- impact of body hair on jellyfish stings [ Time Frame: after recreational saltwater exposure ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy volunteers planning on snorkeling for 30 to 45 minutes.
Exclusion Criteria:
- Pregnancy
- Severe allergy to jellyfish
- Allergy to any topical dermatologic product

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00114894
United States, Florida | |
Dry Tortugas National Park | |
Key West, Florida, United States, 33041 |
Principal Investigator: | David R Boulware, MD | University of Minnesota |
Responsible Party: | David R. Boulware, University of Minnesota |
ClinicalTrials.gov Identifier: | NCT00114894 |
Other Study ID Numbers: |
0311M54041 |
First Posted: | June 20, 2005 Key Record Dates |
Last Update Posted: | April 25, 2023 |
Last Verified: | April 2023 |
Jellyfish Stings Marine Envenomation Jellyfish stings |
Bites and Stings Poisoning Chemically-Induced Disorders Wounds and Injuries |